10x Genomics Inc’s recently made public that its Chief Executive Officer Saxonov Serge unloaded Company’s shares for reported $0.21 million on Mar 04 ’24. In the deal valued at $44.00 per share,4,660 shares were sold. As a result of this transaction, Saxonov Serge now holds 842,900 shares worth roughly $22.03 million.
Then, Saxonov Serge sold 2,821 shares, generating $130,737 in total proceeds. Upon selling the shares at $46.34, the Chief Executive Officer now owns 847,560 shares.
Before that, Hindson Benjamin J. sold 2,613 shares. 10x Genomics Inc shares valued at $121,098 were divested by the insider at a price of $46.34 per share. As a result of the transaction, Hindson Benjamin J. now holds 283,059 shares, worth roughly $7.4 million.
TD Cowen downgraded its 10x Genomics Inc [TXG] rating to a Hold from a a Buy in a research note published on May 01, 2024; the price target was decreased to $32 from $57. A number of analysts have revised their coverage, including Guggenheim’s analysts, who began to cover the stock in mid December with a ‘”a Buy”‘ rating. Wolfe Research began covering TXG with “an Outperform” recommendation on December 13, 2023. BofA Securities revised its rating on December 12, 2023. It rated TXG as “a Neutral” which previously was an “an Underperform”.
Price Performance Review of TXG
On Tuesday, 10x Genomics Inc [NASDAQ:TXG] saw its stock fall -4.07% to $26.14. Over the last five days, the stock has lost -10.72%. 10x Genomics Inc shares have fallen nearly -53.29% since the year began. Nevertheless, the stocks have fallen -51.83% over the past one year. While a 52-week high of $63.57 was reached on 01/02/24, a 52-week low of $24.60 was recorded on 05/01/24. SMA at 50 days reached $35.22, while 200 days put it at $43.67. A total of 1.6 million shares were traded, compared to the trading of 1.39 million shares in the previous session.
Levels Of Support And Resistance For TXG Stock
The 24-hour chart illustrates a support level at 25.42, which if violated will result in even more drops to 24.71. On the upside, there is a resistance level at 27.17. A further resistance level may holdings at 28.20. The Relative Strength Index (RSI) on the 14-day chart is 30.48, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.62, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 68.25%. Stochastics %K at 36.75% indicates the stock is a holding.
